These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6720382)

  • 21. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of lead exposure, serum uric acid and parameters of renal function in Nigerian lead-exposed workers.
    Alasia DD; Emem-Chioma PC; Wokoma FS
    Int J Occup Environ Med; 2010 Oct; 1(4):182-90. PubMed ID: 23022807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal urate hypoexcretion in Polynesian women is not as severe as in United Kingdom (UK) women with familial juvenile hyperuricaemic nephropathy (FJHN).
    McBride MB; Simmonds HA; Hatfield PJ; Graham R; McCaskey J; Jackson M
    Adv Exp Med Biol; 1994; 370():35-8. PubMed ID: 7660926
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
    Einollahi B; Einollahi H; Rostami Z
    Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lead absorption and renal dysfunction in a South African battery factory.
    Ehrlich R; Robins T; Jordaan E; Miller S; Mbuli S; Selby P; Wynchank S; Cantrell A; De Broe M; D'Haese P; Todd A; Landrigan P
    Occup Environ Med; 1998 Jul; 55(7):453-60. PubMed ID: 9816378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mendelian randomization analysis indicates serum urate has a causal effect on renal function in Chinese women.
    Liu J; Zhang H; Dong Z; Zhou J; Ma Y; Li Y; Qian Q; Yuan Z; Zhang J; Yang Y; Wang X; Chen X; Zou H; Jin L; Wang J
    Int Urol Nephrol; 2017 Nov; 49(11):2035-2042. PubMed ID: 28856502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the causes of persistent hyperuricaemia.
    Emmerson BT
    Lancet; 1991 Jun; 337(8755):1461-3. PubMed ID: 1675330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactic acid and hyperuricemia of faulty renal urate transport.
    JAMA; 1967 Jan; 199(2):121-2. PubMed ID: 5225152
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].
    Hu QH; Zhang X; Wang Y; Kong LD
    Yao Xue Xue Bao; 2010 Oct; 45(10):1239-46. PubMed ID: 21348301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between serum uric acid and early kidney damage in middle-aged and elderly].
    He S; Chen XP; Jiang LY; Peng Y; Gong L; Chen XN; Wu K; Cui KJ; Zhu Y; Huang DJ
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):658-61. PubMed ID: 20450722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal hypouricemia due to enhanced tubular secretion of urate associated with urolithiasis: successful treatment of urolithiasis by alkalization of urine K+, Na(+)-citrate.
    Hisatome I; Tanaka Y; Kotake H; Kosaka H; Hirata N; Fujimoto Y; Yoshida A; Shigemasa C; Mashiba H; Sato R
    Nephron; 1993; 65(4):578-82. PubMed ID: 8302413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperuricemic nephropathies.
    Steele TH
    Nephron; 1999; 81 Suppl 1():45-9. PubMed ID: 9873214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
    Yu KH; Luo SF; Tsai WP; Huang YY
    Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?].
    Petriş A; Cimpoeşu D; Petriş O; Costache I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On serum uric acid and endogenic uric acid clearance in renal failure.
    KASANEN A; KALLIO V; MARKKANEN T
    Acta Med Scand; 1958 May; 160(6):503-7. PubMed ID: 13532531
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum laminin P1 fragment and procollagen III in patients with kidney diseases.
    Li Vecchi M; Montalto G; Soresi M; Carroccio A; Renda F; Di Natale E
    Nephron; 1999; 82(3):279-80. PubMed ID: 10396003
    [No Abstract]   [Full Text] [Related]  

  • 39. Does renal impairment protect from gout?
    Youssef P; Brama T; York H; Pickard P; Stewart P; McGill N
    J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.
    Seki S; Tsutsui K; Fujii T; Yamazaki K; Anzawa R; Yoshimura M
    Clin Exp Hypertens; 2010; 32(5):270-7. PubMed ID: 20662727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.